The Onchocerca volvuluscysteine proteinase inhibitor, Ov-CPI-2, is a target of protective antibody response that increases with age

PLoS Neglected Tropical Diseases

Volumn 4, Issue 8, 2010, Pages

  Cho Ngwa, Fidelis ^a,b   Liu, Jing ^a   Lustigman, Sara ^a  

^a NEW YORK BLOOD CENTER   (United States)

^b UNIVERSITY OF BUEA   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; MICROORGANISM PROTEIN; ONCHOCYSTATIN; PARASITE ANTIGEN; PROTEIN CPI 2; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG; CYSTEINE PROTEINASE INHIBITOR; HELMINTH ANTIBODY; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; AGED; AGING; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CAMEROON; CHILD; CONTROLLED STUDY; CYTOTOXICITY; DNA LIBRARY; ENDEMIC DISEASE; FEMALE; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; LARVAL STAGE; MAJOR CLINICAL STUDY; MALE; MOLTING; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PROTEIN TARGETING; ANIMAL; BLOOD; ENZYMOLOGY; GENE LIBRARY; IMMUNOLOGY; LARVA; MIDDLE AGED; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGING; ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; CAMEROON; CHILD; CHILD, PRESCHOOL; CYSTEINE PROTEINASE INHIBITORS; FEMALE; GENE LIBRARY; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; LARVA; MALE; MIDDLE AGED; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; YOUNG ADULT;

EID: 78149237558     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000800     Document Type: Article

References (40)

1. Tropical Disease Research (TDR) (2005) Onchocerciasis: Seventeenth Programme Report/Progress 2003-2004.
2. Lustigman S, Abraham D (2009) Onchocerciasis. In: Vaccines for Biodefense and Emerging and Neglected Diseases Barrett ADT, Stanberry LR, eds. Academic Press Inc, Elsevier Science & Technology. pp 1365-1386.
3. Duke BO, Moore PJ (1968) The contributions of different age groups to the transmission of Onchocerciasis in a Cameroon forest village. Trans R Soc Trop Med Hyg 62: 22-28.
4. Albiez EJ (1983) Studies on nodules and adult Onchocerca volvulus during a nodulectomy trial in hyperendemic villages in Liberia and Upper Volta. I. Palpable and impalpable onchocercomata. Tropenmed Parasitol 34(1): 54-60.
5. Mitchell GF (1990) A note on concomitant immunity in host-parasite relationships: a successfully transplanted concept from tumor immunology. Adv Cancer Res 54: 319-332.
6. MacDonald AJ, Turaga PSD, Harmon-Brown C, Tracy JT, Bennett KE, et al. (2002) Differential Cytokine and Antibody Responses to Adult and Larval Stages of Onchocerca volvulus Consistent with the Development of Concomitant Immunity. Infection and Immunity 70(6): 2796-2804.
7. Day KP, Gregory WF, Maizels RM (1991) Age-specific acquisition of immunity to infective larvae in a bancroftian filariasis endemic area of Papua New Guinea. Parasite Immunol 13: 277-290.
8. Kurniawan-Atmadja A, Sartono E, Partono F, Yazdanbakhsh M, Maizels RM (1998) Antibody responses to filarial infective larvae are not dominated by the IgG4 isotype. Parasite Immunol 20: 9-17.
9. Rajakumar S, Bleiss W, Hartmann S, Schierack P, Marko A, et al. (2006) Concomitant immunity in a rodent model of filariasis: the infection of Meriones unguiculatus with Acanthocheilonema viteae. J Parasitol 92(1): 41-5.
10. Eisenbeiss WF, Apfel H, Meyer TF (1994) Protective immunity linked with a distinct developmental stage of a filarial parasite. J Immunol 152: 735-742.
11. Devaney E, Osborne J (2000) The third-stage larva (L3) of Brugia: its role in immune modulation and protective immunity. Microbes Infect 2: 1363-1371.
12. Lizotte-Waniewski M, Tawe W, Guiliano DB, Lu W, Liu J, et al. (2000) Identification of potential vaccine and drug target candidates by expressed sequence tag analysis and immunoscreening of Onchocerca volvulus larval cDNA libraries. Infect Immun 68(6): 3491-501.
13. Abraham D, Leon O, Leon S, Lustigman S (2001) Development of a recombinant antigen vaccine against infection with the filarial worm Onchocerca volvulus. Infection and Immunity 69: 262-270.
14. Lustigman S, James ER, Tawe W, Abraham D (2002) Towards a recombinant antigen vaccine against Onchocerca volvulus. Trends in Parasitology 18(3): 135-141.
15. Lustigman S, MacDonald AJ, Abraham D (2003) CD4+ dependent immunity to Onchocerca volvulus third-stage larvae in humans and the mouse vaccination model: common ground and distinctions. Int J Parasitol 33(11): 1161-71.
16. Boyer AE, Tsang VC, Eberhand ML (1991) Guatemalan human onchocerciasis ii. Evidence for IgG3 involvement in acquired immunity to O. volvulus and identification of possible immune associated antigens. Journal of Immunology 146: 4001-4010.
17. Ghogomu MS, Souopgui J, Pelle R, Titanji VP (2002) Expression and characterisation of Ov47, a dominant antigen of Onchocerca volvulus. Experimental Parasitology 100: 143-149.
18. Anand SB, Krithika KN, Murugan V, Reddy MV, Kaliraj P (2006) Comparison of Immuno prophylactic efficacy of Bm rALT2 or Bm rVAH or rALT + rVAH by Single and Multiple antigen vaccination mode. American Society of Tropical Medicine and Hygiene 75(5): 295.
19. Gregory WF, Atmadja AK, Allen JE, Maizels RM (2000) The abundant larval transcript-1 and -2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis. Infect Immun 68(7): 4174-9.
20. Wu Y, Egerton G, Pappin DJ, Harrison RA, Wilkinson MC, et al. (2004) Secreted Larval Acidic Proteins (SLAPs) of Onchocerca spp. are encoded by orthologues of the alt gene family of Brugia malayi and have host protective potential. Mol Biochem Parasitol 134(2): 213-24.
21. Johnson EH, Irvine M, Kass PH, Browne J, Abdullai M, et al. (1994) Onchocerca volvulus: in vitro cytotoxic effects of human neutrophils and serum on third-stage larvae. Trop Med Parasitol 45(4): 331-5.
22. Turaga PSD, Tierney TJ, Bennett KE, McCarthy C, Simonek SC, et al. (2000) Immunity to onchocerciasis: Cells from putatively immune individuals produce enhanced levels of interleukin-5, gamma interferon, and granulocyte-macrophage colony-stimulating factor in response to Onchocerca volvulus larval and male worm antigens. Infection and Immunity 68(4): 1905-1911.
23. Lustigman S, Brotman B, Huima T, Prince AM (1991) Characterization of an Onchocerca volvulus cDNA clone encoding a genus specific antigen present in infective larvae and adult worms. Mol Biochem Parasitol 45(1): 65-75.
24. Joseph GT, McCarthy JS, Huima T, Mair KF, Kass PH, et al. (1997) Onchocera volvulus: characterization of a highly immunogenic Gln-rich protein; Mol Biochem Parasitol 90(1): 55-68.
25. McCarthy JS, Wieseman M, Tropea J, Kaslow D, Abraham D, et al. (2002) Onchocerca volvulus glycolytic enzyme fructose-1,6-bisphosphate aldolase as a target for a protective immune response in humans. Infect Immun 70(2): 851-8.
26. Lustigman S, Brotman B, Johnson EH, Smith AB, Huima T, et al. (1992b) Identification and characterization of an Onchocerca volvulus cDNA clone encoding a microfilarial surface-associated antigen. Mol Biochem Parasitol 50(1): 79-93.
27. Graham SP, Lustigman S, Trees AJ, Bianco AE (2000) Onchocerca volvulus: comparative analysis of antibody responses to recombinant antigens in two animal models of onchocerciasis. Exp Parasitol 94(3): 158-62.
28. Lustigman S, Brotman B, Huima T, Prince AM, McKerrow JH (1992a) Molecular cloning and characterisation of onchocystatin, a cysteine proteinase inhibitor of Onchocerca volvulus. J Biol Chem 267: 17339-17346.
29. Lustigman S, McKerrow JH, Shah K, Lui J, Huima T, et al. (1996) Cloning of a cysteine protease required for the molting of Onchocerca volvulus third stage larvae. J Biol Chem 271: 30181-30189.
30. Lustigman S, Zhang J, Liu J, Oksov Y, Hashmi S (2004) RNA interference targeting cathepsin L and Z-like cysteine proteases of Onchocerca volvulus confirmed their essential function during L3 molting. Mol Biochem Parasitol 138(2): 165-70.
31. Shierack P, Lucius R, Sonnenburg B, Schilling K, Hartmann S (2003) Parasitespecific immunomodulatory functions of filarial cystatin. Infect Immun 71(5): 2422-9.
32. Pfaff AW, Schulz-Key H, Soboslay PT, Taylor DW, MacLennan K, et al. (2002) Litomosoides sigmodontis cystatin acts as an immunomodulator during experimental filariasis. Int J Parasitol 32(2): 171-178.
33. Hartman S, Schönemeyer A, Sonnenburg B, Vray B, Lucius R (2002) Cystatins of filarial nematodes up-regulate the nitric oxide production of interferongamma- activated murine macrophages. Parasite Immunol 24(5): 253-62.
34. Bradley JE, Tuan RS, Shepley KJ, Tree TI, Maizels RM, et al. (1993) Onchocerca volvulus: characterization of an immunodominant hypodermal antigen present in adult and larval parasites. Exp Parasitol 77(4): 414-24.
35. Klion AD, Donelson JE (1994) OvGalBP, a filarial antigen with homology to vertebrate galactoside-binding proteins. Mol Biochem Parasitol 65(2): 305-15.
36. Johnson EH, Lustigman S, Kass PH, Irvine M, Browne J, et al. (1995) Onchocerca volvulus: a comparative study of in vitro neutrophil killing of microfilariae and humoral responses in infected and endemic normals. Exp Parasitol 81(1): 9-19.
37. Tume C, Sun E, Titanji V, Bathurst I, Barr P, et al. (1995) Onchocerca volvulus: identification and characterization of an immunogenic eggshell protein (Oveg1). Exp Parasitol 81(4): 445-52.
38. Joseph GT, Huima T, Klion A, Lustigman S (2000) A novel developmentally regulated galectin of Onchocerca volvulus. Mol Biochem Parasitol 106(1): 187-95.
39. Lu W, Egerton GL, Bianco AE, Williams SA (1998) Thioredoxin peroxidase from Onchocerca volvulus: a major hydrogen peroxide detoxifying enzyme in filarial parasites. Mol Biochem Parasitol 91(2): 221-35.
40. Chandrashekar R, Curtis KC, Weil GJ (1995) Molecular characterization of a parasite antigen in sera from onchocerciasis patients that is immunologically cross-reactive with human keratin. J Infect Dis 171(6): 1586-92.